# Dexmedetomidine Versus Propofol for Continuous Sedation in the Intensive Care Unit (ICU)

> **NCT00479661** · PHASE3 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 500 (actual)

## Conditions studied

- Continuous Sedation in Initially Sedated Adults in ICU

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT00479661
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2010-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00479661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00479661, "Dexmedetomidine Versus Propofol for Continuous Sedation in the Intensive Care Unit (ICU)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00479661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*